Abbisko (HKG:2256) reported 322.5 million yuan in attributable profit for the six months ended June 30, up from the 216.9 million yuan in the year-ago period, according to a Hong Kong bourse filing Monday.

Shares of the biopharmaceutical company rose nearly 5% in recent Tuesday trade.

Diluted earnings of 0.51 yuan per share compared to the 0.32 yuan per share a year prior.

The firm generated 612.1 million yuan in the first six months of the year, rising from 497.3 million yuan a year earlier.